Versão HTML básica
397
Information for Authors
Rev Bras Hematol Hemoter. 2012;34(5):397
The
Revista Brasileira deHematologia eHemoterapia,
ISSN1516 8484, the official
scientific publication of the Associação Brasileira de Hematologia, Hemoterapia e Terapia
Celular, Sociedade Brasileira de Transplante de Medula Óssea, Associazione Italo-Brasiliana
di Ematologia and Sociedade Brasileira de Oncologia Pediátrica aims to promote scientific
development in Hematology, Transfusion Medicine and related areas. All manuscripts, after
initial acceptance by the editors, will be sent for analysis by two peer reviewers. Anonymity
is guaranteed throughout the evaluation process. When considered necessary, a list of
modifications will be sent to authors to correct their work or justify their decision not to do so.
The responsibility for opinions expressed in articles is solely of the authors.
Manuscripts should not be submitted simultaneously to more than one journal.
This is an Open Access article distributed under the terms of the Creative Commons
Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)
which permits unrestricted non-commercial use, distribution, and reproduction in any
medium, provided the original work is properly cited. Reproduction, in full or partial,
translated into other languages requires prior permission of the editors.
The journal publishes the following sessions: Original Article, Special Article,
Review Article, Updates in the Specialty, Case report, Letter to the Editor, Images in
Clinical Hematology, Editorial, Scientific Comment and What is the Evidence. Other
types of publications of interest in the area will be published at the discretion of the
editors. All articles will be published in English however at the start of the review process
manuscripts can be submitted in Portuguese or English.
Preparation of the manuscript
General information
For any manuscript to be evaluated, it must be accompanied by the following
documentation:
• Conflict of interest: Situations that may improperly influence the development or
the conclusions of the work such as participation in drug- or equipment-producing
companies cited or used in the work, as well as competitors of these companies
should be mentioned. Financial assistance, payments received for consultancies,
relationships related to employment, etc. are also considered sources of conflict.
• Approval of the study by a Research Ethics Committee recognized by the National
Research Ethics Committee (CONEP);
• Articles that deal with clinical research involving human beings must include a
statement in the Methods Section that all study participants signed an informed
consent form. Authors should also confirm that the study was conducted in
accordance with the Helsinki Declaration as revised in 2008;
• For works involving animal experimentation, the authors should confirm in the
Methods Section that the study followed the rules contained in the Ethical Code for
Animal Experimentation of the Council for International Organizations of Medical
Sciences (CIOMS) [WHO Chronicle 1985; 39 (2): 51-6] and the principles of
the Brazilian College of Animal experimentation - COBEA (www.cobea.org.br).
Authors must complete the Declaration - Statement of Human and Animal Rights.
All randomized controlled trials and clinical trials submitted for publication
must be registered in a clinical trials database. This is a guideline of the International
Clinical Trial Registry Platform (ICTPR) of the World Health Organization (WHO) and
the International Committee of Medical Journal Editors (ICMJE). The instructions for
the registry are available at http: www.icmje.orgclintrialup.htm and registration can be
attained in the Clinical Trials Database of the National Library of Medicine available at
http://clinicaltrials.gov/ct/gui.
Technical requirements
1.
Article identification:
a) A concise however informative title; b) Complete names of
authors without abbreviations and their institutions; c) Department and official name
of the institution(s) to which the work should be attributed; d) Name, full address
including telephone and e-mail of corresponding author; e) financial support (if any).
2.
Abstract and keywords:
Abstract in English of not more than 250 words. For
Original Articles this should be structured with background, method, main results
and conclusion. For the other article types, the abstract need not be structured but
should contain information illustrating the importance of the work. Specify up to five
keywords, which define the theme of the paper. The keywords should be based on
MeSH (Medical Subject Headings) from the National Library of Medicine available
at: http://www.sgponline.com.br/rbhh/sgp/naveg/mesh.asp. For clinical trials, indicate
the International Clinical Trials Registry Number below the summary.
3.
Manuscript content:
a) Original Article:
Used to publish the results of scientific
research, it must be original and should comprise the following: Introduction,
Objective, Method, Results, Discussion, Conclusion and References. The work
should not exceed 4000 words (including references), up to 6 authors, up to 7 tables,
illustrations and photos and up to 30 references;
b) Special Article:
With the same
structure as original articles, Original Articles are reclassified by the Editor depending
on their importance:
C) Review Articles:
narrative reviews addressing an important
issue in the specialty. These articles should not exceed 5000 words (including
references), a maximum of 7 tables, Figures and Photos and up to 60 references;
d) Update in the Specialty:
on a theme, method, treatment, etc. It must contain a
brief history of the topic, its current state of knowledge and the reasons for the work;
study methods (data sources, selection criteria), hypotheses, study lines, etc., criteria
similar to review articles:
e) Case Report:
should have an introduction with a brief
literature review, a description of the case showing significant results for the diagnosis
and differential diagnoses (if any), discussion or comments and references. It should
not exceed 1800 words, two tables, illustrations and photographs, up to four authors
and ten references:
f) Letters to the Editor:
a maximum of 1000 words (including
references), three authors, and two illustrations:
g) Images in Clinical Hematology:
Maximum 100 words, two images, three authors and three references:
h) Scientific
comments:
will only be accepted by invitation of the editors.
4.
Acknowledgements:
Should be addressed to collaborators who deserve
recognition, but whose participation does not justify their inclusion as an author
such as technical assistants, as well as financial support received.
5.
References:
References should always be numbered in the order they appear in
the text. The format must be based on the “Uniform Requirements for Manuscripts
Submitted to Biomedical Journals” guidelines proposed by the International
Committee of Medical Journal Editors and updated in 2009, as follows: the titles
of journals should be abbreviated following the List of Journals Indexed in Index
Medicus of the National Library of Medicine (http://www.ncbi.nlm.nih.gov/sites/
entrez). Cite the first six authors after which add the words et al.
Examples of references: Printed documents
•
Journals:
Padley DJ, Dietz AB, Gastineau DA. Sterility testing of hematopoietic
progenitor cell products: a single-institution series of culture-positive rates and
successful infusion of culture-positive products. Transfusion. 2007;47(4):636-43.
•
Books:
Chalmers J. Clinician’s manual on blood pressure and stroke prevention. 3rd
ed. London: Science Press; 2002. 70 p.
Richardson MD, Warnock DW. Fungal Infection Diagnosis and Management. 2
nd
ed.
Oxford: Blackwell Science Ltd Editorial Offices; 1997.249 p.
•
Book chapters:
F. Reyes. Lymphocyte differentiation. In P Solal-Céligny, N
Brousse, F Reyes, C Gisselbrecht, B Coiffier. Non-Hodgkin`s Lymphomas. Paris:
Éditions Frison-Roche; 1993. p.19-29.
•
Annals:
Souza AM, Vaz RS, Carvalho MB, Arai Y, Hamerschilak N. Prevalência de
testes sorológicos relacionados à hepatitis B e não-A, não-B em doadores de sangue.
In: 19º Congresso Brasileiro de Hematologia e Hemoterapia / 26º Congresso da
Sociedade Brasileira de Hematologia e Hemoterapia; 2003 Ago 6-9; São Paulo,
2003. Anais
.
p.103.
•
Theses:
Sandes AF. Caracterização imunofenotípica da diferenciação eritrocitária,
granulocítica e megacariótica em pacientes com síndromes mielodisplásicas
[thesis]. São Paulo: Universidade Federal de São Paulo; 2009. 126p.
Electronic documents
•
Articles in Periodicals:
Almeida ID, Coitinho AS, Juckowsky CA, Schmalfuss
T, Balsan AM, Röhsig LM. Controle de esterilidade de produtos de células
progenitoras hematopoéticas do sangue periférico. Rev Bras Hematol Hemoter
[Internet] 2010 [cited 2010 Jun 10]; 32(1):23-8. Available from: http://www.scielo.
br/pdf/rbhh/v32n1/aop03010.pdf
•
Books:
Walker HK, Hall WD, Hurst JW, editors. Clinical methods. The history,
physical, and laboratory examinations. 3rd ed. [Internet]. Boston: Butterworths;
1990. [cited 2010 Jun 10]. Available from: http://www.ncbi.nlm.nih.gov/bookshelf/
br.fcgi?book=cm
•
Illustrations and photos:
Must have a resolution of at least 1000 dpi. Color figures
should be in CMYK and will be published in color only if essential and must be in
TIFF, JPEG or CDR format. Do not send the figures within the text.
•
Tables:
should be numbered consecutively using Arabic numerals and cited in the
text in numerical order. If the table requires special symbols, it should be sent as a
high resolution image (1000 dpi) in TIFF or JPG format.
Submission
The submission of the manuscript must be via the website of the Revista Brasileira
de Hematologia e Hemoterapia, (Journal of Hematology and Hemoterapy) www.rbhh.
org. A copyright transfer form (available on the website) must be completed and signed
by all authors and sent to the editorial office e-mail brazilbloodjournal@yahoo.com.br.
When a manuscript is accepted for publication, the author(s) will be requested to
complete a conflict of interest form which must be sent to the editorial office.
It is the responsibility of authors to obtain written permission to reproduce any
previously published data included in the manuscript.
The editors can publish papers that do not exactly follow the instructions after
careful evaluation always taking into account the interests of the readership.
Correspondence address:
Milton Artur Ruiz
Editor in Chief
Rua Catarina Nucci Parise, 760 - Jardim Vivendas
São Jose do Rio Preto, SP, Brazil
CEP 15090-470